Your session is about to expire
← Back to Search
TCU Opioid-Treatment Linkage Model for Opioid Addiction (JCOIN_TCU Trial)
JCOIN_TCU Trial Summary
This trial is examining two different study periods in order to gather information on the referral process for treatment and to learn about the relationships between medical and communitybehavioral health providers.
JCOIN_TCU Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.JCOIN_TCU Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Horizontal implementation approach
- Group 2: Vertical implementation approach
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many people will be given the opportunity to participate in this clinical trial?
"Yes, the trial is currently ongoing and recruiting patients. It was first posted on October 7th 2021 and was last updated February 28th 2022. The study needs 18 more participants at 1 site."
Are we still looking for people to participate in this research project?
"From what is published on clinicaltrials.gov, this clinical trial is still looking for test subjects. The original posting date was 10/7/2021 with the latest update on 2/28/2022."
What are the dangers associated with TCU Opioid-Treatment Linkage Model (O-TLM)?
"While there is some data supporting the safety of TCU Opioid-Treatment Linkage Model (O-TLM), it falls into Phase 2 of clinical trials and has not yet been proven effective. Consequently, our team at Power rates its safety a 2."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger